TY - JOUR
T1 - Internet-Based Monitoring in the Severe Asthma Research Program Identifies a Subgroup of Patients With Labile Asthma Control
AU - National Heart Lung and Blood Institute's Severe Asthma Research Program-3 Investigators
AU - Wong-McGrath, Kelly
AU - Denlinger, Loren C.
AU - Bleecker, Eugene R.
AU - Castro, Mario
AU - Gaston, Ben
AU - Israel, Elliot
AU - Jarjour, Nizar N.
AU - Mauger, David T.
AU - Peters, Stephen
AU - Phillips, Brenda R.
AU - Wenzel, Sally E.
AU - Fahy, John V.
AU - Peters, Michael C.
N1 - Funding Information:
Financial/nonfinancial disclosures: The authors have reported to CHEST the following: L. C. D. has consulted for GSK. E. R. B. has undertaken clinical trials through his employer Wake Forest School of Medicine and the University of Arizona and AstraZeneca, Medimmune, Boehringer Ingelheim, Cephalon/Teva, Genentech, GSK, Johnson & Johnson (Janssen), Novartis, and Sanofi Regeneron. He has also served as a paid consultant for AstraZeneca, Medimmune, Boehringer Ingelheim, GSK, Novartis, and Sanofi Regeneron outside the submitted work. M. C. currently receives pharmaceutical grant monies from Medimmune, Teva, GSK, Boehringer Ingelheim, Invion, Gilead, and Sanofi Aventis. Royalties are received from Elsevier. E. I. reports receiving consulting fees from AstraZeneca, Bird Rock Bio, Novartis, Nuvelution Pharmaceuticals, Philips Respironics, Regeneron Pharmaceuticals, TEVA Specialty Pharmaceuticals, and Vitaeris, Inc.; travel grant support from Research in Real Life (RIRL) and TEVA Specialty Pharmaceuticals; Deputy Editor fees from the American Thoracic Society; DSMB Member for Novartis with no compensation, and grant support paid to his institution from Genentech, Sanofi, and the National Institutes of Health (NIH). D. T. M. reports grant support from the NIH. J. V. F. has acted as a paid consultant to Sanofi Genzyme and Boehringer Ingelheim and has received grant monies from the NIH. M. C. P. has acted as a paid consultant to Merck, has participated in speaking activities at Genentech and Amgen, and reports grant support from the NIH. None declared (K. W. M., B. G., N. N. J., S. P., B. R. P., S. E. W.).
Funding Information:
FUNDING/SUPPORT: This study was funded by the National Institutes of Health [Grants PO1 HL107201, R01 HL080414, K23 HL138303, U19AI077439, U10 HL109146, U10 HL109164, U10 HL109172, U10 HL109086, U10 HL109250, U10 HL109168, U10HL109257, and U10 HL109152] and by grants from the Parker B. Francis Foundation.
Publisher Copyright:
© 2017 American College of Chest Physicians
PY - 2018/2
Y1 - 2018/2
N2 - Background: We designed an Internet-Based Monitoring Systems (IBS) survey to facilitate monitoring of asthma symptoms and asthma exacerbations in the Severe Asthma Research Program (SARP). Our objective was to evaluate compliance with the IBS survey tool and to explore how data from an IBS tool can inform understanding of asthma phenotypes. Methods: We invited adult subjects in the SARP III cohort (N = 528) to complete a monthly IBS asthma control survey. We compared the characteristics of subjects who did and those who did not participate in the IBS survey tool. Among subjects who participated in the IBS (IBS+), we identified participants with low, medium, and high Asthma Control Test (ACT) score variability, and we explored asthma morbidity in these three participant subgroups. Results: Two hundred fifty-nine subjects participated in the IBS (IBS+) survey. Compared with subjects who did not engage with the IBS (IBS–) survey, IBS+ subjects were older and more likely to be white, college educated, and have an annual household income > $25,000, and have controlled asthma. Among IBS+ participants, the subgroup with the highest ACT score variability was more likely to have severe asthma, with a lower ACT score at baseline and increased asthma-related health-care use (often precipitated by cold and flulike illnesses). Participants with high ACT variability were also characterized by metabolic dysfunction, as evidenced by obesity and hypertension. Conclusions: Active participation with an Internet-based symptom survey tool in patients with severe asthma is influenced by race, socioeconomic status, and asthma control. Among survey participants, a group with highly variable (labile) asthma control is identifiable as a specific subgroup with unmet treatment needs. The association of asthma lability, increased susceptibility to adverse asthma effects of cold and flulike illnesses, and metabolic dysfunction provides clues for potentially effective intervention strategies.
AB - Background: We designed an Internet-Based Monitoring Systems (IBS) survey to facilitate monitoring of asthma symptoms and asthma exacerbations in the Severe Asthma Research Program (SARP). Our objective was to evaluate compliance with the IBS survey tool and to explore how data from an IBS tool can inform understanding of asthma phenotypes. Methods: We invited adult subjects in the SARP III cohort (N = 528) to complete a monthly IBS asthma control survey. We compared the characteristics of subjects who did and those who did not participate in the IBS survey tool. Among subjects who participated in the IBS (IBS+), we identified participants with low, medium, and high Asthma Control Test (ACT) score variability, and we explored asthma morbidity in these three participant subgroups. Results: Two hundred fifty-nine subjects participated in the IBS (IBS+) survey. Compared with subjects who did not engage with the IBS (IBS–) survey, IBS+ subjects were older and more likely to be white, college educated, and have an annual household income > $25,000, and have controlled asthma. Among IBS+ participants, the subgroup with the highest ACT score variability was more likely to have severe asthma, with a lower ACT score at baseline and increased asthma-related health-care use (often precipitated by cold and flulike illnesses). Participants with high ACT variability were also characterized by metabolic dysfunction, as evidenced by obesity and hypertension. Conclusions: Active participation with an Internet-based symptom survey tool in patients with severe asthma is influenced by race, socioeconomic status, and asthma control. Among survey participants, a group with highly variable (labile) asthma control is identifiable as a specific subgroup with unmet treatment needs. The association of asthma lability, increased susceptibility to adverse asthma effects of cold and flulike illnesses, and metabolic dysfunction provides clues for potentially effective intervention strategies.
KW - Internet-based monitoring
KW - asthma control
KW - labile asthma
KW - metabolic dysfunction
KW - obesity
UR - http://www.scopus.com/inward/record.url?scp=85041922781&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85041922781&partnerID=8YFLogxK
U2 - 10.1016/j.chest.2017.10.017
DO - 10.1016/j.chest.2017.10.017
M3 - Article
C2 - 29080709
AN - SCOPUS:85041922781
SN - 0012-3692
VL - 153
SP - 378
EP - 386
JO - CHEST
JF - CHEST
IS - 2
ER -